2 Increasing costs of diabetes care stem in large part from increased diagnosis and prevalence of diabetes, in addition to increased costs of outpatient services, supplies, and outpatient medications, 2,3 especially insulin 4 and newer antidiabetes medications (ADMs)
doi: 10.1007/s00204-013-1074-9
Pharmaceuticals must demonstrate safety and efficacy before being marketed
By purchasing, you confirm compliance with all applicable regulations regarding research compounds
PlexusDx compounded GLP-1 protocols similarly carry transparent per-month pricing ($129/mo to $349/mo) bundled into a single subscription with no consultation fees simplifying budget planning for patients without GLP-1 coverage
George, evidence-based treatments such as semaglutide and tirzepatide help many patients lose 1521% of their total body weight (when using FDA-approved medications), resulting in meaningful improvements in long-term health